Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NVCT | WVE |
|---|---|---|
| Price | $20.29 | $3.54 |
| Change today | ▲ 1.30% | ▲ 0.57% |
| Market cap | $662.35M | $697.55M |
| Return, 3 months | +6.8% | -43.9% |
| Return, year to date | +168.7% | -79.2% |
| Return, 1 year | +225.7% | -51.8% |
| P/E (TTM) | -15.4 | -3.3 |
| P/B | 73.0 | 1.5 |
| P/E percentile vs own 5y | 4th | 64th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | -73.9% |
| Net profit growth (YoY) | -10.8% | -37.4% |
| Gross margin | – | – |
| Operating margin | – | -333.4% |
| Net margin | – | -309.7% |
| Return on equity | -233.3% | -68.3% |
| Analyst target vs. price | +69.2% | +416.1% |
| Analyst buy share | 100% | 92% |
| RSI (14) | 44 | 27 |
| 30-day volatility | 62.9% | 44.9% |
| Max drawdown, 1 year | -36.8% | -83.5% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
